Eli Lilly and Company Canadian Depositary ReceiptEli Lilly and Company Canadian Depositary ReceiptEli Lilly and Company Canadian Depositary Receipt

Eli Lilly and Company Canadian Depositary Receipt

No trades
See on Supercharts

Key facts today


Eli Lilly's obesity drugs, Mounjaro and Zepbound, were found less effective than Novo Nordisk's Wegovy in reducing heart attack and stroke risks, based on a study of over 21,000 patients.
Analyze the impactAnalyze the impact
Market capitalization
‪953.07 B‬CAD
0.58CAD
‪14.51 B‬CAD
‪61.71 B‬CAD
Beta (1Y)

About Eli Lilly and Company


CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
CA28655A1066
FIGI
BBG01JDLZ5K4
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Check out other big names from the same industry as LLY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
Maturity date
Feb 27, 2063
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
Maturity date
Aug 14, 2064
LLY6003479
Eli Lilly and Company 4.9% 12-FEB-2032
Yield to maturity
Maturity date
Feb 12, 2032
LLY.GG
Eli Lilly and Company 6.77% 01-JAN-2036
Yield to maturity
Maturity date
Jan 1, 2036
LLY6003396
Eli Lilly and Company 5.5% 12-FEB-2055
Yield to maturity
Maturity date
Feb 12, 2055
LLY6003480
Eli Lilly and Company 4.55% 12-FEB-2028
Yield to maturity
Maturity date
Feb 12, 2028
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065
Yield to maturity
Maturity date
Feb 12, 2065
LLY5750404
Eli Lilly and Company 4.5% 09-FEB-2029
Yield to maturity
Maturity date
Feb 9, 2029
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047
Yield to maturity
Maturity date
May 15, 2047
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
Maturity date
Jun 15, 2044
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
Maturity date
Feb 9, 2064

See all LLY bonds